Method for determining a risk of hyperglycemic patients to develop cardiovascular disease.

摘要

An in vitro method of evaluating a risk of a diabetic patient to develop atherosclerotic cardiovascular disease (CVD), the method comprising determining a haptoglobin phenotype of the diabetic patient and evaluate thereby the risk of the diabetic patient to develop cardiovascular disease (CVD ) atherosclerotic, wherein the risk is decreased in diabetic patients with haptoglobin 1-1 phenotype as compared to patients with haptoglobin 1-2 phenotypes or haptoglobin 2-2.